NCT03535792View on ClinicalTrials.gov

Nalbuphine Versus Fentanyl As Additives To Bupivacaine In Spinal Anaesthesia For Internal FixationI Of Tibia

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 4, 2017

Primary Completion Date

August 19, 2018

Study Completion Date

August 20, 2018

Conditions
Pain, Postoperative
Interventions
DRUG

Fentanyl/Hyperbaric bupivacaine

Intrathecal Fentanyl/Hyperbaric bupivacaine and Tibial internal fixation.

DRUG

Nalbuphine/Hyperbaric bupivacaine

Intrathecal Nalbuphine/Hyperbaric bupivacaine and Tibial internal fixation.

Trial Locations (1)

21111

Alexandria Faculty of Medicine, Alexandria

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT03535792 - Nalbuphine Versus Fentanyl As Additives To Bupivacaine In Spinal Anaesthesia For Internal FixationI Of Tibia | Biotech Hunter | Biotech Hunter